In 2026, healthcare organizations face unprecedented revenue cycle challenges. The shift to value-based care demands exceptional clinical documentation and risk adjustment. AI-powered prior authorization creates new workflow complexities. Federal funding volatility threatens margins. Denial rates persist despite sophisticated appeal programs. Meanwhile, physician resistance remains the single biggest barrier to revenue cycle improvement initiatives. Traditional revenue cycle

Claim denials cost U.S. healthcare providers billions of dollars annually, yet more than 80% are preventable. For healthcare executives, this represents both a critical challenge and a significant opportunity. Denial management is no longer just a billing function—it's a strategic imperative that requires executive-level attention and cross-departmental alignment. Understanding the True Cost of Denials The financial impact of denials extends far beyond immediate revenue loss.

As healthcare continues its transformation from fee-for-service to value-based care, revenue integrity has evolved from a back-office function to a strategic imperative requiring C-suite attention. Organizations that succeed in this new landscape share one common trait: strong executive leadership committed to cultural change and cross-functional alignment. The Changing Definition of Revenue Integrity In fee-for-service models, revenue integrity focused primarily on accurate